US · Healthcare

Enliven Therapeutics Inc. (ELVN)

Biotechnology

Enliven Therapeutics Inc. (ELVN) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for ELVN

P/E ratio

18.00

Enliven Therapeutics Inc. (ELVN) — FAQ

What is ELVN's P/E ratio?

The price-to-earnings (P/E) ratio for Enliven Therapeutics Inc. (ELVN) is 18.00 (data as of 2026-03-24).

Does Enliven Therapeutics Inc. pay a dividend?

Dividend yield is not available in the current snapshot for Enliven Therapeutics Inc. (ELVN). Check the MyAverix Finance app for the latest dividend data.

What sector is Enliven Therapeutics Inc. in?

Enliven Therapeutics Inc. (ELVN) is classified in the Healthcare sector (Biotechnology industry).

What exchange is ELVN listed on?

ELVN is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)